Free Trial
LON:TSTL

Tristel (TSTL) Share Price, News & Analysis

Tristel logo
GBX 420 +3.00 (+0.72%)
As of 12:31 PM Eastern

About Tristel Stock (LON:TSTL)

Key Stats

Today's Range
416.70
420
50-Day Range
350
417
52-Week Range
260
572.50
Volume
251,703 shs
Average Volume
101,277 shs
Market Capitalization
£200.64 million
P/E Ratio
30.74
Dividend Yield
3.10%
Price Target
GBX 400
Consensus Rating
Hold

Company Overview

Tristel Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
9th Percentile Overall Score

TSTL MarketRank™: 

Tristel scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Tristel has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Tristel has only been the subject of 1 research reports in the past 90 days.

  • Read more about Tristel's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Tristel is 30.74, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.29.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Tristel is 30.74, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.58.

  • Price to Book Value per Share Ratio

    Tristel has a P/B Ratio of 6.15. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for TSTL.
  • Dividend Leadership

    Tristel is a leading dividend payer. It pays a dividend yield of 3.86%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Tristel does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Tristel is 95.14%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Read more about Tristel's dividend.
  • Short Interest

    There is no current short interest data available for TSTL.
  • News Sentiment

    Tristel has a news sentiment score of 1.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.01 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Tristel this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Tristel insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.89% of the stock of Tristel is held by insiders.

  • Percentage Held by Institutions

    50.37% of the stock of Tristel is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Tristel's insider trading history.
Receive TSTL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tristel and its competitors with MarketBeat's FREE daily newsletter.

TSTL Stock News Headlines

Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
See More Headlines

TSTL Stock Analysis - Frequently Asked Questions

Tristel's stock was trading at GBX 421.60 at the beginning of 2025. Since then, TSTL stock has decreased by 0.4% and is now trading at GBX 420.

Tristel plc (LON:TSTL) issued its quarterly earnings data on Monday, February, 24th. The company reported $8.17 earnings per share for the quarter. Tristel had a trailing twelve-month return on equity of 20.43% and a net margin of 15.47%.

Shares of TSTL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tristel investors own include Standard Life Aberdeen (SL), Barclays (BARC), BP (BP), Capital One Financial (COF), Lloyds Banking Group (LLOY), Automatic Data Processing (ADP) and Ashtead Group (AHT).

Company Calendar

Last Earnings
2/24/2025
Today
7/14/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
LON:TSTL
CIK
N/A
Fax
N/A
Employees
208
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 13.66
Trailing P/E Ratio
29.69
Forward P/E Ratio
24.90
P/E Growth
N/A
Net Income
£6.54 million
Net Margins
15.47%
Pretax Margin
N/A
Return on Equity
20.43%
Return on Assets
9.89%

Debt

Debt-to-Equity Ratio
18.09
Current Ratio
3.75
Quick Ratio
3.83

Sales & Book Value

Annual Sales
£42.24 million
Price / Sales
4.59
Cash Flow
GBX 19.36 per share
Price / Cash Flow
20.96
Book Value
GBX 68.34 per share
Price / Book
5.94

Miscellaneous

Outstanding Shares
47,770,446
Free Float
N/A
Market Cap
£193.83 million
Optionable
Not Optionable
Beta
0.23
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (LON:TSTL) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners